Lactococcus garvieae endocarditis in a native valve identified by MALDI-TOF MS and PCR-based 16s rRNA in Spain: A case report  by Heras Cañas, V. et al.
NEW MICROBES IN HUMANSLactococcus garvieae endocarditis in
a native valve identiﬁed by MALDI-
TOF MS and PCR-based 16s rRNA
in Spain: A case reportV. Heras Cañas1, M. D. Pérez Ramirez1,
F. Bermudez Jiménez2, M. D. Rojo Martin1, C. Miranda Casas1,
M. Marin Arriaza3 and J. M. Navarro Marí1
1) Department of Microbiology, 2) Department of Cardiology, University
Hospital Virgen de las Nieves, Granada and 3) Department of Molecular
Biology, University General Hospital Gregorio Marañon, Madrid, Spain
AbstractLactococcus garvieae is a Gram-positive, catalase negative coccus
arranged in pairs or short chains, well-known as a ﬁsh pathogen.
We report a case of Infective Endocarditis (IE) by L. garvieae in a
native valve from a 68-year-old male with unknown history of
contact with raw ﬁsh and an extensive history of heart disease.
This case highlights the reliability of MALDI-TOF MS compared
to conventional methods in the identiﬁcation of rare
microorganisms like this.
New Microbes and New Infections © 2015 The Authors. Published
by Elsevier Ltd on behalf of European Society of Clinical
Microbiology and Infectious Diseases.
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E-mail: victor_heras_88@hotmail.comIntroductionLactococcus garvieae is a Gram-positive, catalase-negative coccus
arranged in pairs or short chains that was formerly included in
the lactic group of Streptococcus. However, this coccus was
eventually excluded from this group in 1985 basing on 16S
rRNA sequencing data. Since L. garvieae is a well-known ﬁshNew Microbes and New Infections © 2015 The Authors. Published by El
This is an open access artipathogen, human infections are usually related to contact with
raw ﬁsh. Infective Endocarditis (IE) by L.garvieae is extremely
unusual and may involve both native and prosthetic valves. Due
to its morphology and biochemical similarities with the
Enterococcus genus, L.garvieae IE is probably underdiagnosed.CaseWe present the case of a 68-year-old male with hypertension,
dyslipidemia, Hodking Lymphoma in remission and a long his-
tory of heart disease: implantation of a DDD-mode pacemaker
due to a complete atrioventricular block, aortic valve replace-
ment with a mechanical prosthetic Sorin 18mm-valve as a result
of severe degenerative aortic stenosis, and signiﬁcant peri-
prosthetic regurgitation requiring percutaneous repair with an
Amplatzer-type device.
In February 2014, the patient presented to the Emergency
Department with fever of unknown origin of ten days duration.
Laboratory data revealed elevation of acute phase reactants
(PCR 24.9mg/dl, PCT 0.72ng/ml), as well as neutrophilic
leukocytosis, so one set of blood culture was taken. The patient
was discharged home with a prescription for empirical antimi-
crobial treatment with cefditoren 400mg/12h.
Blood culture grew Gram-positive, catalase-negative cocci
arranged in short chains with gamma-haemolysis on blood agar
after 24h incubation and blue colonies on CHROMAGAR
(BD®). Susceptibility testing directly performed from blood
culture revealed its sensitivity to vancomycin, ampicillin, cefo-
taxime, and oxacillin, so we discarded the Enterococcus genus.
MALDI-TOF MS mass spectrometry (Bruker Daltonics®)
identiﬁed it as Lactococcus garvieae with a good score (2.126).
Two weeks later, the patient returned to the Emergency
Department in bad clinical condition compatible with acute
heart failure (IV NYHA functional class). On suspicion of IE, the
patient was admitted in Cardiology Department, where an
emergency transthoracic echocardiography (TTE) was per-
formed, revealing a calciﬁed mitral valve with vegetations and
possible rupture of the posterior leaﬂet, with moderate-high
failure. Thus, empirical antibiotic therapy was started with
daptomycin 850mg/48h, ampicillin 2g/6h and ceftriaxone 2g/12h
and new blood cultures were taken.
Next, we performed the susceptibility testing according the
CLSI guidelines employing the Epsilon-Test method to evaluate
the following antibiotics (Table 1): penicillin-I (MIC: 0.75mg/dl)
cefotaxime-S (MIC: 0.38mg/dl), erythromycin-S (MIC: 0.25mg/
dl), vancomycin-S (MIC: 1mg/dl), daptomycin-S (MIC: 1mg/dl),
levoﬂoxacin-S (MIC: 1.5 mg/dl) and clindamycin-R (MIC: 1mg/
dl). Due to the lack of experimental data for the interpretationNew Microbe and New Infect 2015; 5: 13–15
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TABLE 1. Susceptibility pattern of Lactococcus garvieae
isolated in our patient carried out by E-test method
Antibiotic MIC (μg/ml) Interpretation
Penicillin 0.75 I
Cefotaxime 0.38 S
Erythromycin 0.25 S
Vancomycin 1 S
Daptomycin 1 S
Levoﬂoxacin 1.5 S
Clindamycin 1 R
14 New Microbes and New Infections, Volume 5 Number C, May 2015 NMNIof MICs in the Lactococcus genus, we used Streptococcus spp.
breakpoints as a reference [1]. The susceptibility pattern
conﬁrmed that the microorganism was Lactococcus garvieae [2].
Following conﬁrmation of the bacterial species, gentamicin was
added to improve the treatment of IE. However, gentamicin
was discontinued as a result of acute renal failure after three
days of treatment. All blood cultures collected on Cardiology
Department were negative.
Later, a transesophageal echocardiography (TEE) was per-
formed, showing the presence of mitral abscesses in addition to
what was observed in TTE. The patient was referred for
replacement surgery of the native mitral valve with a prosthetic
Sorin 27mm-valve. The course was complicated involving
persistent shock and multiorganic failure resulting in patient’s
death the same day of surgery.
The mitral valve removed in the surgical intervention was
sent to the Microbiology Department of our institution for
analysis. Culture of the valve was negative with no microor-
ganisms observed in Gram stain. To conﬁrm the diagnosis of IE
caused by L. garvieae, a fragment of heart valve tissue was sent
to Clinical Microbiology Department of University Hospital
Gregorio Marañón, in Madrid, for analysis only by 16S rRNA
gene PCR and sequencing. These tests conﬁrmed the presence
of Lactococcus garvieae in the native mitral valve.DiscussionLactococcus spp. is mainly associated to infective endocarditis,
but it may be involved in lumbar osteomyelitis [3], hepatic
abscess [4] and hip prosthetic infections [5]. Generally,
L. garvieae IE has been associated with contact with raw ﬁsh
[6–9], but in our case, the origin was unknown. Digestive pa-
thologies such as colonic diverticulosis [9], duodenal ulcer [10]
and colonic polyps [11] could be risk factors for L. garvieae IE.
In most reported cases of IE caused by this pathogen, the
treatment of choice was gentamicin in combination with a beta-
lactam or vancomycin for at least four weeks, with good clinical
outcomes [9]. A case of death has been described in a patientNew Microbes and New Infections © 2015 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licewith native valve endocarditis who was treated with ceftriaxone
alone. In our case, the incorporation of gentamicin to the
antimicrobial treatment had to be interrupted due to acute
renal failure and the patient ultimate death.
Lactococcus spp. is commonly misidentiﬁed as Enterococcus
faecalis, [2,11] because both have similar morphological char-
acteristics. Furthermore, they are catalase-negative, PYR-posi-
tive, grow on 6.5% NaCl and can hydrolyze esculin.
Differentiating Lactococcus spp. from Enterococcus faecalis can be
difﬁcult even through carbohydrate fermentation. Both are
mannitol, maltose and fructose positive, but arabinose and
rafﬁnose negative [12,13]. The main reproducible difference is
the fermentation of sorbitol, which is negative in the former
and positive in the latter. It is also possible to use two other
carbohydrates -xylose and rhamnose-, but ﬁve to seven days
are required to see any difference: Lactococcus spp. is xylose
negative and rhamnose positive, whereas Enterococcus faecalis is
xylose positive and rhamnose weakly positive. It is also known
that Lactococcus grows slower than Enterococcus at 45°C,
although this difference is not observed in some cases [6].
Furthermore, it is possible to discriminate between L. garvieae
and L. lactis because the former is resistant to clindamycin and
has intermediate susceptibility to penicillin, whereas the latter is
susceptible to both antibiotics [7,9].
The use of matrix-assisted laser desorption ionization-time
of ﬂight mass spectrometry (MALDI-TOF MS) at our institu-
tion let us a simple and rapid identiﬁcation of the microor-
ganism. The later conﬁrmation through sequencing of the heart
valve supported the reliable identiﬁcation from MALDI-TOF.
The extraction of only one set of blood culture hampered
the evaluation of this pathogen, because of the possibility of
being a contamination as usually happens when species from the
Streptococcus genus are isolated. The subsequent blood cultures
taken to conﬁrm the isolation of L. garvieae were negative,
probably due to the antimicrobial treatment previously
received.
There are few reported cases of L. garvieae IE in the world
(currently only two cases have been described in Spain) [14],
but it appears to be an emerging pathogen that matches with
the development of whole-cell protein patterns and nucleic acid
ampliﬁcation technologies, such as mass-spectrometry MALDI-
TOF MS and PCR and sequencing of 16s rRNA gene,
respectively.
In conclusion, the best way to identify L. garvieae is through
MALDI-TOF MS and 16s rRNA gene PCR, in addition to sus-
ceptibility proﬁle, which allowed us to differentiate it from
Enterococcus spp. Also, we would like to emphasize the
importance of the extraction of two sets of blood cultures to
perform a reliable assessment of the microorganism isolated,
and the importance to discard IE when L. garvieae is isolatedEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 5, 13–15
nses/by-nc-nd/4.0/)
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